vs
Axe Compute Inc.（AGPU）与Enovis CORP（ENOV）财务数据对比。点击上方公司名可切换其他公司
Enovis CORP的季度营收约是Axe Compute Inc.的63282.5倍（$548.9M vs $8.7K）。Enovis CORP净利率更高（-104.1% vs -1740028.0%，领先1739923.9%）。Axe Compute Inc.同比增速更快（-1.3% vs -2.2%）。过去两年Axe Compute Inc.的营收复合增速更高（33.6% vs 9.8%）
Enovis是一家专注于骨科领域的医疗科技企业，其前身是1995年由米切尔·雷尔斯和史蒂文·雷尔斯兄弟创立的科尔法克斯公司。公司总部位于特拉华州威尔明顿，目前在全球12个地点开展业务，拥有超过5000名员工，于纽约证券交易所上市，股票代码为ENOV。
AGPU vs ENOV — 直观对比
营收规模更大
ENOV
是对方的63282.5倍
$8.7K
营收增速更快
AGPU
高出0.8%
-2.2%
净利率更高
ENOV
高出1739923.9%
-1740028.0%
两年增速更快
AGPU
近两年复合增速
9.8%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $8.7K | $548.9M |
| 净利润 | $-150.9M | $-571.1M |
| 毛利率 | — | 59.9% |
| 营业利润率 | -1990880.1% | -101.7% |
| 净利率 | -1740028.0% | -104.1% |
| 营收同比 | -1.3% | -2.2% |
| 净利润同比 | -6856.6% | 18.8% |
| 每股收益（稀释后） | — | $-9.99 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGPUENOV
| Q4 25 | $8.7K | $548.9M | ||
| Q3 25 | $3.6K | $564.5M | ||
| Q2 25 | $2.7K | $558.8M | ||
| Q1 25 | $110.3K | — | ||
| Q4 24 | $8.8K | $561.0M | ||
| Q3 24 | $3.9K | $505.2M | ||
| Q2 24 | $67.3K | $525.2M | ||
| Q1 24 | $4.9K | $516.3M |
净利润AGPUENOV
| Q4 25 | $-150.9M | $-571.1M | ||
| Q3 25 | $-77.7M | $-36.7M | ||
| Q2 25 | $-2.1M | $-56.0M | ||
| Q1 25 | $-2.4M | — | ||
| Q4 24 | $-2.2M | $-703.2M | ||
| Q3 24 | $-3.1M | $-31.5M | ||
| Q2 24 | $-3.2M | $-18.6M | ||
| Q1 24 | $-4.2M | $-72.0M |
毛利率AGPUENOV
| Q4 25 | — | 59.9% | ||
| Q3 25 | -131.0% | 59.3% | ||
| Q2 25 | -579.4% | 59.5% | ||
| Q1 25 | 59.1% | — | ||
| Q4 24 | -250.5% | 54.8% | ||
| Q3 24 | -186.1% | 56.7% | ||
| Q2 24 | 79.4% | 55.0% | ||
| Q1 24 | -361.8% | 57.7% |
营业利润率AGPUENOV
| Q4 25 | -1990880.1% | -101.7% | ||
| Q3 25 | -90654.1% | -3.0% | ||
| Q2 25 | -99174.8% | -8.4% | ||
| Q1 25 | -2073.3% | — | ||
| Q4 24 | -23848.9% | -118.5% | ||
| Q3 24 | -55296.7% | -6.3% | ||
| Q2 24 | -3664.6% | -8.4% | ||
| Q1 24 | -73734.7% | -6.8% |
净利率AGPUENOV
| Q4 25 | -1740028.0% | -104.1% | ||
| Q3 25 | -2146264.3% | -6.5% | ||
| Q2 25 | -77198.4% | -10.0% | ||
| Q1 25 | -2214.6% | — | ||
| Q4 24 | -24676.9% | -125.4% | ||
| Q3 24 | -79208.9% | -6.2% | ||
| Q2 24 | -4730.1% | -3.5% | ||
| Q1 24 | -86843.2% | -13.9% |
每股收益（稀释后）AGPUENOV
| Q4 25 | — | $-9.99 | ||
| Q3 25 | — | $-0.64 | ||
| Q2 25 | — | $-0.98 | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $-12.69 | ||
| Q3 24 | — | $-0.58 | ||
| Q2 24 | — | $-0.34 | ||
| Q1 24 | — | $-1.32 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $10.8M | $33.6M |
| 总债务越低越好 | — | $1.4B |
| 股东权益账面价值 | $47.7M | $2.0B |
| 总资产 | $52.9M | $4.4B |
| 负债/权益比越低杠杆越低 | — | 0.67× |
8季度趋势，按日历期对齐
现金及短期投资AGPUENOV
| Q4 25 | $10.8M | $33.6M | ||
| Q3 25 | $181.7K | $44.1M | ||
| Q2 25 | $506.1K | $38.5M | ||
| Q1 25 | $3.1M | — | ||
| Q4 24 | $611.8K | $48.2M | ||
| Q3 24 | $3.1M | $35.4M | ||
| Q2 24 | $5.3M | $35.0M | ||
| Q1 24 | $5.2M | $66.3M |
总债务AGPUENOV
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.4B | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.3B | ||
| Q1 24 | — | $1.3B |
股东权益AGPUENOV
| Q4 25 | $47.7M | $2.0B | ||
| Q3 25 | $-77.4M | $2.6B | ||
| Q2 25 | $-1.7M | $2.6B | ||
| Q1 25 | $-145.8K | — | ||
| Q4 24 | $-202.6K | $2.6B | ||
| Q3 24 | $2.0M | $3.3B | ||
| Q2 24 | $4.1M | $3.3B | ||
| Q1 24 | $4.1M | $3.3B |
总资产AGPUENOV
| Q4 25 | $52.9M | $4.4B | ||
| Q3 25 | $3.1M | $5.0B | ||
| Q2 25 | $3.4M | $4.9B | ||
| Q1 25 | $5.9M | — | ||
| Q4 24 | $5.0M | $4.7B | ||
| Q3 24 | $7.5M | $5.6B | ||
| Q2 24 | $10.6M | $5.4B | ||
| Q1 24 | $10.6M | $5.5B |
负债/权益比AGPUENOV
| Q4 25 | — | 0.67× | ||
| Q3 25 | — | 0.54× | ||
| Q2 25 | — | 0.53× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.52× | ||
| Q3 24 | — | 0.40× | ||
| Q2 24 | — | 0.41× | ||
| Q1 24 | — | 0.40× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-3.9M | $82.6M |
| 自由现金流经营现金流 - 资本支出 | — | $29.1M |
| 自由现金流率自由现金流/营收 | — | 5.3% |
| 资本支出强度资本支出/营收 | 0.0% | 9.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $22.8M |
8季度趋势，按日历期对齐
经营现金流AGPUENOV
| Q4 25 | $-3.9M | $82.6M | ||
| Q3 25 | $-1.7M | $47.8M | ||
| Q2 25 | $-3.3M | $-1.6M | ||
| Q1 25 | $-985.8K | — | ||
| Q4 24 | $-2.1M | $88.3M | ||
| Q3 24 | $-2.5M | $53.6M | ||
| Q2 24 | $-3.2M | $7.8M | ||
| Q1 24 | $-3.4M | $-36.2M |
自由现金流AGPUENOV
| Q4 25 | — | $29.1M | ||
| Q3 25 | — | $3.4M | ||
| Q2 25 | — | $-44.9M | ||
| Q1 25 | — | — | ||
| Q4 24 | $-2.1M | $35.1M | ||
| Q3 24 | — | $2.4M | ||
| Q2 24 | — | $-31.6M | ||
| Q1 24 | $-3.4M | $-73.1M |
自由现金流率AGPUENOV
| Q4 25 | — | 5.3% | ||
| Q3 25 | — | 0.6% | ||
| Q2 25 | — | -8.0% | ||
| Q1 25 | — | — | ||
| Q4 24 | -23429.1% | 6.3% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | -6.0% | ||
| Q1 24 | -70379.8% | -14.2% |
资本支出强度AGPUENOV
| Q4 25 | 0.0% | 9.7% | ||
| Q3 25 | 0.0% | 7.9% | ||
| Q2 25 | 0.0% | 7.7% | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 73.7% | 9.5% | ||
| Q3 24 | 0.0% | 10.1% | ||
| Q2 24 | 0.0% | 7.5% | ||
| Q1 24 | 62.4% | 7.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AGPU
暂无分部数据
ENOV
| Reconstructive Segment | $258.0M | 47% |
| Surgical | $129.0M | 23% |
| Prevention And Recovery | $92.6M | 17% |
| Other Prevention And Recovery | $71.4M | 13% |
